Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001641172-25-006669
Filing Date
2025-04-29
Accepted
2025-04-29 16:45:09
Documents
17
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT form10-ka.htm   iXBRL 10-K/A 80500
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex31-1.htm EX-31.1 18407
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 18386
  Complete submission text file 0001641172-25-006669.txt   544891

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ocea-20241231.xsd EX-101.SCH 4007
5 XBRL DEFINITION FILE ocea-20241231_def.xml EX-101.DEF 30931
6 XBRL LABEL FILE ocea-20241231_lab.xml EX-101.LAB 85045
7 XBRL PRESENTATION FILE ocea-20241231_pre.xml EX-101.PRE 64077
19 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 10206
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40793 | Film No.: 25888616
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)